Froedtert Hospital/Medical College of Wisconsin

Milwaukee, Wisconsin 533226

4 studies enrolling now · 41 studies all time

What they study most

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia (AML), Advanced Breast Cancer, Advanced Lung Carcinoma, Aortic Valve Stenosis, Bladder Cancer, Blood Pressure, Brain Metastases, Burkitt Lymphoma, Carcinoma, Non-Small-Cell Lung, Central Nervous System Lymphoma

Studies at this site

• LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve — Recruiting now
• A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma — Recruiting now
• A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2 — Recruiting now
• Long-term Follow-up Study of Patients Receiving CAR-T Cells — Recruiting now
• Impella RP Flex with Smart Assist — Recruiting now
• Clinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus Topotecan or Irinotecan in Patients With Relapsed Small-cell Lung Cancer (LAGOON) — Completed
• Assessment of Optune Therapy for Patients With Newly Diagnosed Glioblastoma Using Advanced MRI — Running, not enrolling
• Cemiplimab in High-risk or Locally Advanced Luminal and Triple Negative Breast Cancer — Running, not enrolling
• Comparison Between ABP 692 and Ocrevus® (Ocrelizumab) — Running, not enrolling
• A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer — Running, not enrolling
• A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer — Running, not enrolling
• Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma — Running, not enrolling
• Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA) — Completed
• A Communication Tool to Improve Communication in the ICU — Running, not enrolling
• Study of Sacituzumab Govitecan (SG) Versus Docetaxel in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) — Running, not enrolling
• Analyzing Preoperative Stereotactic Radiosurgery With Gamma Knife Icon for Brain Metastases — Completed
• Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC) — Running, not enrolling
• Study of Anitocabtagene-autoleucel in Participants With Relapsed Refractory Multiple Myeloma — Running, not enrolling
• A Study of Ripretinib vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib — Running, not enrolling
• A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer — Completed
• RECOVER-VITAL: Platform Protocol to Measure the Effects of Antiviral Therapies on Long COVID Symptoms — Completed
• Selexipag (ACT-293987) in Pulmonary Arterial Hypertension — Completed
• To Evaluate Efficacy and Safety of Serplulimab + Chemotherapy (Carboplatin- Etoposide) in US Patients With ES-SCLC — Running, not enrolling
• Study Comparing Investigational Drug HBI-8000 + Nivolumab vs. Placebo + Nivolumab in Patients With Advanced Melanoma — Running, not enrolling
• TTX-030 in Combination With Immunotherapy and/or Chemotherapy in Subjects With Advanced Cancers — Completed
• A Study to Investigate LYL797 in Adults With Solid Tumors — Stopped early
• Study of Magrolimab in Combination With Azacitidine Versus Physician's Choice of Venetoclax in Combination With Azacitidine or Intensive Chemotherapy in Patients With TP53 Mutant Acute Myeloid Leukemia That Have Not Been Treated — Stopped early
• A Study of Talazoparib in Men With DNA Repair Defects and Metastatic Castration-Resistant Prostate Cancer — Completed
• CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers — Completed
• Study of CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell — Completed
• The Life After Stopping Tyrosine Kinase Inhibitors Study (The LAST Study) — Completed
• A Phase 1b/2 Study of OMP-59R5 (Tarextumab) in Combination With Nab-Paclitaxel and Gemcitabine in Subjects With Previously Untreated Stage IV Pancreatic Cancer — Completed
• REPRISE IV: LOTUS Edge Valve System in Intermediate Surgical Risk Subjects — Stopped early
• An Investigational Immuno-therapy Study of Ulocuplumab in Combination With Low Dose Cytarabine in Patients With Newly Diagnosed Acute Myeloid Leukemia — Stopped early
• Study of ADCT-301 in Patients With Relapsed or Refractory Hodgkin and Non-Hodgkin Lymphoma — Completed
• PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Participants With Stage IV Untreated Pancreatic Cancer — Completed
• Measurement of NonInvasive Blood Pressure in Neonates Through Adults and Special Populations — Stopped early
• A Phase 1B Study to Investigate the Safety and Preliminary Efficacy for the Combination of Dasatinib Plus Nivolumab in Patients With Chronic Myeloid Leukemia — Completed
• Study of ADCT-301 in Patients With Relapsed/Refractory CD25-positive Acute Myeloid Leukemia (AML) or CD25-positive Acute Lymphoblastic Leukemia (ALL) — Stopped early
• Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML) — Completed
• Safety and Tolerability of MEDI-545 in Patients Who Have Systemic Lupus Erythematosus (SLE) — Completed